Confirmatory

Related by string. confirmatory * * confirmatory due diligence . initiated confirmatory Phase . confirmatory pivotal . confirmatory Phase III . confirmatory Phase 3 . confirmatory tests . confirmatory clinical . confirmatory Phase IIIb . confirmatory testing . Phase III confirmatory . Confirmatory Order . confirmatory Phase . undertake confirmatory . Confirmatory tests *

Related by context. Frequent words. (Click for all words.) 66 Pivotal Phase III 65 Phase IIB 65 Phase III Clinical Trial 65 Clinical Trial Results 65 Diagnostic Tests 65 Bioequivalence 64 Drug Candidate 63 Initiate Phase 62 Meets Primary Endpoint 62 Improves Survival 62 Epidermal Growth Factor Receptor 62 Metastatic Melanoma 62 Patient Enrollment 62 Immunogenicity 61 preclinical efficacy 61 Pivotal Phase 61 Smallpox Vaccine 61 Drug Resistant 61 Recombinant Human 61 Renal Cell Carcinoma 61 Hepatocellular Carcinoma 61 Malaria Vaccine 61 Pivotal Study 61 Inactivation 61 Phase III Trial 61 Cancer Vaccines 60 Retest 60 Commences Phase 60 Targeted Therapy 60 Testwork 60 Prognostic 60 NMP# 60 Inhaled Insulin 60 Gastric Cancer 60 Epratuzumab 60 Preclinical Data 60 FDA Accepts 60 Alemtuzumab 59 Metallurgical testwork 59 Toxicological 59 Myelodysplastic Syndromes 59 Benign Prostatic Hyperplasia 59 Pulmonary Arterial Hypertension 59 Monoclonal Antibody 59 Mucosal 59 Pivotal Trial 59 RNAi Therapeutics 59 Acute Ischemic Stroke 59 phase Ib 59 II Clinical Trial 59 Gene Mutation 59 Bone Mineral Density 59 Metastatic Colorectal Cancer 59 Single Dose 59 Androgen 58 Monotherapy 58 FDA Clearance 58 Oritavancin 58 Drug Shows Promise 58 Significantly Improved 58 Prostate Cancer Treatment 58 Vitro Diagnostic 58 Pralatrexate 58 Anthrax Vaccine 58 Initiates Phase II 58 FDA Clears 58 confirmatory 58 Low Dose 58 Sample Preparation 58 Randomized controlled 58 Lactate 58 Pharmacokinetic 58 Phase Ib clinical 58 Combination Therapy 58 Polymorphism 58 Chronic Hepatitis C 58 Tumor Growth 58 Patent Covering 58 Preliminary metallurgical 58 Angiographic 58 Factor VIIa 58 histopathological 58 immunohistochemical 58 Ischemic 57 Well Tolerated 57 PROSTVAC TM 57 Bioavailability 57 Overactive Bladder 57 nonclinical studies 57 Microspheres 57 Help Predict 57 Protease 57 IND submission 57 Receives Orphan Drug Designation 57 Chronic Lymphocytic Leukemia 57 microbiologic 57 Retesting 57 KRAS mutation 57 Immunohistochemistry 57 Prostate Cancer Patients 57 preclinical toxicology

Back to home page